SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* JAGGERS JOHN V (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol SPLUNK INC [ SPLK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 04/24/2012
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/24/2012		C		16,431,632	A	(1)	16,431,632	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Preferred Stock	(1)	04/24/2012		C		10,000,000		(1)	(1)	Common Stock	10,000,000	$0	0	I	See Footnote(3)
Series B Preferred Stock	(1)	04/24/2014		C		3,981,286		(1)	(1)	Common Stock	3,981,286	$0	0	I	See Footnote(4)
Series C Preferred Stock	(1)	04/24/2012		C		2,232,478		(1)	(1)	Common Stock	2,232,478	$0	0	I	See Footnote(5)

1. Name and Address of Reporting Person* JAGGERS JOHN V (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* BAYLESS JON W (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* DOW STEPHEN M (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* DOMENIK STEPHEN L (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* KIMZEY JACKIE R (Last) (First) (Middle) SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS, TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* PHIPPS CHARLES H (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* SCHUELE ALAN R (Last) (First) (Middle) C/O SEVIN ROSEN FUNDS 13455 NOEL ROAD, SUITE 1670 (Street) DALLAS TX 75240 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date.

2. Total common shares of 16,431,632,represents 16,070,097 of such shares held by Sevin Rosen Fund VIII L.P. ("SRFVIII"), 327,961 of such shares held by Sevin Rosen VIII Affiliates Fund L.P. ("SRVIII AFF") and 33,574 of such shares held by Sevin Rosen Bayless Management Company ("SRBMC"). John V. Jaggers ("Jaggers"), Jon W. Bayless ("Bayless"), Stephen M. Dow ("Dow"), Stephen L. Domenik ("Domenik"), Jackie R. Kimzey ("Kimzey"), Charles H. Phipps ("Phipps") and Alan R. Schuele ("Schuele") are general partners of the general partner of SRFVIII and SRVIII AFF. Messers Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele disclaim beneficial ownership of these shares except to the extent of his porportionate interest in these shares. As directors of SRBMC they are deemed to have shared voting and dispositive power of these shares and disclaim benefical ownership with no pecuniary interest.

3. Total Series A Preferred shares of 10,000,000, represents 9,772,560 of such preferred shares held by SRFVIII, 199,440 of such preferred shares held by SRVIII AFF, and 28,000 of such preferred shares held by SRBMC. Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele are general partners of the general partner of SRFVIII and SRVIII AFF, and dislaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares. Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele are directors of SRBMC and are deemed to have shared voting and dispositive power of these shares and disclaim beneficial ownership with no pecuniary interest in these shares.

4. Total Series B Preferred shares of 3,981,286, represents 3,896,198 of such preferred shares held by SRFVIII, 79,514 of such preferred shares held by SRVIII AFF, and 5,574 of such preferred shares held by SRBMC. Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele are general partners of the general partner of SRFVIII and SRVIII AFF, and dislaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares. Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele are directors of SRBMC and are deemed to have shared voting and dispositive power of these shares and disclaim beneficial ownership with no pecuniary interest in these shares.

5. Total Series C Preferred shares of 2,232,478, represents 2,187,828 of such preferred shares held by SRFVIII and 44,650 of such preferred shares held by SRVIII AFF. Jaggers, Bayless, Dow, Domenik, Kimzey, Phipps and Schuele are general partners of the general partner of SRFVIII and SRVIII AFF, and dislaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares. X E Signature Data Signature of Reporting Person * Date * Remarks (2000 chars max): chars left

	John V. Jaggers	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Jon W. Bayless	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Stephen M. Dow	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Stephen L. Domenik	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Jackie R. Kimzey	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Charles H. Phipps	04/24/2012
	John V. Jaggers, As Attorney-In-Fact For Alan R. Schuele	04/24/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.